Z. F. Karagonlar Et Al. , "Elevated hepatocyte growth factor expression as an autocrine c-Met activation mechanism in acquired resistance to sorafenib in hepatocellular carcinoma cells," CANCER SCIENCE , vol.107, no.4, pp.407-416, 2016
Karagonlar, Z. F. Et Al. 2016. Elevated hepatocyte growth factor expression as an autocrine c-Met activation mechanism in acquired resistance to sorafenib in hepatocellular carcinoma cells. CANCER SCIENCE , vol.107, no.4 , 407-416.
Karagonlar, Z. F., Koc, D., İŞCAN, E., Erdal, E., & Atabey, N., (2016). Elevated hepatocyte growth factor expression as an autocrine c-Met activation mechanism in acquired resistance to sorafenib in hepatocellular carcinoma cells. CANCER SCIENCE , vol.107, no.4, 407-416.
Karagonlar, Zeynep Et Al. "Elevated hepatocyte growth factor expression as an autocrine c-Met activation mechanism in acquired resistance to sorafenib in hepatocellular carcinoma cells," CANCER SCIENCE , vol.107, no.4, 407-416, 2016
Karagonlar, Zeynep F. Et Al. "Elevated hepatocyte growth factor expression as an autocrine c-Met activation mechanism in acquired resistance to sorafenib in hepatocellular carcinoma cells." CANCER SCIENCE , vol.107, no.4, pp.407-416, 2016
Karagonlar, Z. F. Et Al. (2016) . "Elevated hepatocyte growth factor expression as an autocrine c-Met activation mechanism in acquired resistance to sorafenib in hepatocellular carcinoma cells." CANCER SCIENCE , vol.107, no.4, pp.407-416.
@article{article, author={Zeynep Firtina Karagonlar Et Al. }, title={Elevated hepatocyte growth factor expression as an autocrine c-Met activation mechanism in acquired resistance to sorafenib in hepatocellular carcinoma cells}, journal={CANCER SCIENCE}, year=2016, pages={407-416} }